Weekly Digest - Jan 2024

Weekly Digest - Jan 2024

17 Jan 2024: Orion invests $415.6M in LegoChem Biosciences to lead in next-gen anticancer drugs with ADC technology

  • Orion invests $415.6 million to acquire a 25% stake in biotech firm LegoChem Biosciences, becoming its largest shareholder
  • The acquisition, set to finalize on Mar. 29, positions Orion as the majority shareholder, integrating LegoChem Bio into its corporate family while maintaining the biotech firm’s existing management and operational framework
  • LegoChem Bio, known for its ADC technology, has successfully negotiated 13 out-licensing agreements since 2015, amounting to a total contract value of $6.6 billion

For full story click here

Share this

Facebook
fb-share-icon
Twitter
Tweet
LinkedIn
Share
Home